NASDAQ: IMMX
IMMIX Biopharma Inc Stock Ownership - Who owns IMMIX Biopharma?

Insider buying vs selling

Have IMMIX Biopharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gabriel S. MorrisCFO2025-12-10770$6.58
$5.07kBuy
Ilya M. RachmanCEO and Chairman2025-12-10746$6.67
$4.98kBuy
Gabriel S. MorrisCFO2025-12-08156,000$0.80
$124.80kBuy

1 of 1

IMMX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IMMX insiders and whales buy or sell their stock.

IMMX Shareholders

What type of owners hold IMMIX Biopharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Yekaterina Chudnovsky4.54%3,247,326$41.31MInsider
Ilya M. Rachman1.60%1,141,683$14.52MInsider
Carey Ng1.47%1,051,471$13.37MInsider
Jason Hsu1.33%949,250$12.07MInsider
Nancy T. Chang1.29%925,130$11.77MInsider
Vladimir P. Torchilin1.27%905,200$11.51MInsider
Sean Senn1.26%899,800$11.45MInsider
Gabriel S. Morris0.44%315,570$4.01MInsider
Helen C. Adams0.25%181,004$2.30MInsider
Magda Marquet0.13%92,342$1.17MInsider

1 of 3

IMMX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IMMX0.08%13.64%Net Buying
FTH0.05%31.12%Net BuyingNet Buying
AVTX0.09%99.91%Net SellingNet Selling
TBPH0.09%82.27%Net SellingNet Selling
LXRX0.03%99.97%Net Buying

IMMIX Biopharma Stock Ownership FAQ

Who owns IMMIX Biopharma?

IMMIX Biopharma (NASDAQ: IMMX) is owned by 0.08% institutional shareholders, 13.64% IMMIX Biopharma insiders, and 86.28% retail investors. Yekaterina Chudnovsky is the largest individual IMMIX Biopharma shareholder, owning 3.25M shares representing 4.54% of the company. Yekaterina Chudnovsky's IMMIX Biopharma shares are currently valued at $40.59M.

If you're new to stock investing, here's how to buy IMMIX Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.